Insider Trading activities of Ptc Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ptc Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ptc Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Ptc Therapeutics, Inc. since 2005. The reporting company's ticker symbol is PTCT. The reporting company's CIK number is 1070081.
The total value of stock buying since 2005 is $54,838,320.
The total value of stock sales since 2005 is $42,063,709.
The total value of stock option exercises since 2005 is $6,476,184.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ptc Therapeutics, Inc. (PTCT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 25,000 $337,225 0 $0 12,000 $130,200
2017-03 0 $0 0 $0 2,966 $32,181
2017-02 0 $0 0 $0 3,125 $33,906
2017-01 0 $0 78 $921 3,125 $33,906
2016-11 0 $0 0 $0 1,941 $21,059
2016-10 0 $0 0 $0 1,950 $21,157
2016-09 0 $0 0 $0 82,200 $891,870
2016-03 2,000 $12,460 0 $0 0 $0
2016-01 0 $0 0 $0 3,125 $33,906
2015-07 0 $0 23,604 $1,129,687 24,216 $262,743
2015-06 0 $0 168,849 $9,250,674 176,359 $1,913,494
2015-05 0 $0 82,491 $4,586,087 78,991 $1,496,879
2015-04 0 $0 9,511 $653,358 0 $0
2015-03 0 $0 169,455 $12,099,556 11,000 $119,350
2015-02 0 $0 38,904 $2,575,490 35,904 $389,558
2015-01 0 $0 43,245 $2,579,799 37,492 $406,787
2014-12 0 $0 3,182 $169,901 3,230 $35,044
2014-11 0 $0 2,173 $86,050 2,396 $25,996
2014-10 0 $0 87,578 $3,453,372 49,894 $541,348
2014-09 0 $0 26,000 $1,086,755 8,000 $86,800
2014-05 0 $0 1,650 $24,321 0 $0
2014-03 0 $0 101,434 $3,095,599 0 $0
2014-02 23,000 $563,500 0 $0 0 $0
2013-12 0 $0 66,667 $1,272,139 0 $0
2013-06 3,595,009 $53,925,135 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ptc Therapeutics, Inc. insiders (PTCT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-24 Rothera Mark (Chief Commercial Officer) Option Ex 2,000 10.85 21,700
2017-05-23 Svoronos Dawn Buy 25,000 13.49 337,225
2017-05-09 Kovacs Shane William Charles (Chief Financial Officer) Option Ex 10,000 10.85 108,500
2017-03-15 Rothera Mark (Chief Commercial Officer) Option Ex 2,966 10.85 32,181
2017-02-16 Rothera Mark (Chief Commercial Officer) Option Ex 3,125 10.85 33,906
2017-01-17 Rothera Mark (Chief Commercial Officer) Option Ex 3,125 10.85 33,906
2017-01-05 Almstead Neil Gregory (EVP Research Pharma Ops & Tech) Sale 78 11.82 921
2016-11-14 Rothera Mark (Chief Commercial Officer) Option Ex 1,941 10.85 21,059
2016-10-10 Rothera Mark (Chief Commercial Officer) Option Ex 1,950 10.85 21,157
2016-09-27 Almstead Neil Gregory (EVP Research Pharma Ops & Tech) Option Ex 10,000 10.85 108,500
2016-09-26 Kovacs Shane William Charles (Chief Financial Officer) Option Ex 10,000 10.85 108,500
2016-09-26 Rothera Mark (Chief Commercial Officer) Option Ex 2,200 10.85 23,870
2016-09-23 Schmertzler Michael Option Ex 60,000 10.85 651,000
2016-03-03 Rothera Mark (Chief Commercial Officer) Buy 2,000 6.23 12,460
2016-01-15 Rothera Mark (Chief Commercial Officer) Option Ex 3,125 10.85 33,906
2015-07-21 Rothera Mark (Chief Commercial Officer) Option Ex 9,216 10.85 99,993
2015-07-06 Southwell David P Sale 23,604 47.86 1,129,687
2015-07-06 Southwell David P Option Ex 15,000 10.85 162,750
2015-06-18 Jacobson Allan Steven Sale 5,000 50.13 250,650
2015-06-17 Peltz Stuart Walter (Chief Executive Officer) Option Ex 3,500 10.85 37,975
2015-06-09 Peltz Stuart Walter (Chief Executive Officer) Sale 26,300 53.61 1,409,864
2015-06-09 Peltz Stuart Walter (Chief Executive Officer) Option Ex 26,300 10.85 285,355
2015-06-08 Peltz Stuart Walter (Chief Executive Officer) Sale 73,700 55.14 4,063,818
2015-06-08 Peltz Stuart Walter (Chief Executive Officer) Option Ex 77,476 10.85 840,614
2015-06-08 Boulding Mark Elliott (Exec VP and CLO) Sale 56,849 55.15 3,135,392
2015-06-08 Boulding Mark Elliott (Exec VP and CLO) Option Ex 62,083 10.85 673,600
2015-06-08 Aldrich Richard (Director) Sale 7,000 55.85 390,950
2015-06-08 Aldrich Richard (Director) Option Ex 7,000 10.85 75,950
2015-05-22 Kovacs Shane William Charles (Chief Financial Officer) Sale 82,491 55.59 4,586,087
2015-05-22 Kovacs Shane William Charles (Chief Financial Officer) Option Ex 78,991 18.95 1,496,879
2015-04-15 Almstead Neil Gregory (EVP Research Pharma Ops & Tech) Sale 9,511 68.69 653,358
2015-03-23 Peltz Stuart Walter (Chief Executive Officer) Sale 47,200 69.77 3,293,285
2015-03-23 Southwell David P Sale 2,317 69.45 160,915
2015-03-20 Boulding Mark Elliott (Exec. VP and CLO) Sale 21,142 68.75 1,453,575
2015-03-19 Almstead Neil Gregory (EVP Research Pharma Ops & Tech) Sale 20,370 70.85 1,443,255
2015-03-18 Jacobson Allan Steven Sale 16,616 76.21 1,266,272
2015-03-17 Rothera Mark (Chief Commercial Officer) Sale 10,700 76.64 820,048
2015-03-17 Rothera Mark (Chief Commercial Officer) Option Ex 10,700 10.85 116,095
2015-03-16 Kranda Michael L Sale 2,500 72.93 182,325
2015-03-13 Rothera Mark (Chief Commercial Officer) Sale 300 76.36 22,908
2015-03-13 Rothera Mark (Chief Commercial Officer) Option Ex 300 10.85 3,255
2015-03-13 Spiegel Robert J. (Chief Medical Officer) Sale 1,030 75.53 77,790
2015-03-10 Almstead Neil Gregory (EVP, Research and CMC) Sale 79 70.71 5,586
2015-03-09 Peltz Stuart Walter (Chief Executive Officer) Sale 47,201 71.47 3,373,597
2015-02-25 Rothera Mark (Chief Commercial Officer) Sale 11,000 73.49 808,390
2015-02-25 Rothera Mark (Chief Commercial Officer) Option Ex 11,000 10.85 119,350
2015-02-24 Rothera Mark (Chief Commercial Officer) Sale 1,000 67.70 67,700
2015-02-24 Rothera Mark (Chief Commercial Officer) Option Ex 1,000 10.85 10,850
2015-02-23 Rothera Mark (Chief Commercial Officer) Sale 23,000 64.73 1,488,721
2015-02-23 Rothera Mark (Chief Commercial Officer) Option Ex 20,000 10.85 217,000
2015-02-17 Almstead Neil Gregory (EVP, Research and CMC) Sale 3,904 53.97 210,679
2015-02-17 Almstead Neil Gregory (EVP, Research and CMC) Option Ex 3,904 10.85 42,358
2015-01-21 Almstead Neil Gregory (EVP, Research and CMC) Sale 996 60.00 59,760
2015-01-21 Almstead Neil Gregory (EVP, Research and CMC) Option Ex 996 10.85 10,806
2015-01-20 Almstead Neil Gregory (EVP, Research and CMC) Sale 25,100 60.63 1,521,938
2015-01-20 Almstead Neil Gregory (EVP, Research and CMC) Option Ex 25,100 10.85 272,335
2015-01-20 Rothera Mark (Chief Commercial Officer) Sale 3,000 60.02 180,060
2015-01-16 Rothera Mark (Chief Commercial Officer) Sale 2,300 58.67 134,941
2015-01-16 Rothera Mark (Chief Commercial Officer) Option Ex 2,300 10.85 24,955
2015-01-15 Hirawat Claudia De Oliveira Ribeiro (President) Sale 2,149 57.19 122,901
2015-01-15 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 2,396 10.85 25,996
2015-01-14 Rothera Mark (Chief Commercial Officer) Sale 1,200 58.62 70,344
2015-01-14 Rothera Mark (Chief Commercial Officer) Option Ex 1,200 10.85 13,020
2015-01-13 Rothera Mark (Chief Commercial Officer) Sale 8,500 57.63 489,855
2015-01-13 Rothera Mark (Chief Commercial Officer) Option Ex 5,500 10.85 59,675
2014-12-31 Hirawat Claudia De Oliveira Ribeiro (President) Sale 417 52.39 21,846
2014-12-31 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 417 10.85 4,524
2014-12-15 Hirawat Claudia De Oliveira Ribeiro (President) Sale 2,173 55.62 120,862
2014-12-15 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 2,396 10.85 25,996
2014-12-04 Almstead Neil Gregory (Senior VP, Research and CMC) Sale 175 50.00 8,750
2014-12-01 Hirawat Claudia De Oliveira Ribeiro (President) Sale 417 44.23 18,443
2014-12-01 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 417 10.85 4,524
2014-11-17 Hirawat Claudia De Oliveira Ribeiro (President) Sale 2,173 39.60 86,050
2014-11-17 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 2,396 10.85 25,996
2014-10-31 Hirawat Claudia De Oliveira Ribeiro (President) Sale 416 41.50 17,264
2014-10-31 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 416 10.85 4,513
2014-10-15 Hirawat Claudia De Oliveira Ribeiro (President) Sale 2,172 35.73 77,594
2014-10-15 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 2,395 10.85 25,985
2014-10-10 Hirawat Claudia De Oliveira Ribeiro (President) Sale 43,489 36.18 1,573,432
2014-10-10 Hirawat Claudia De Oliveira Ribeiro (President) Option Ex 47,083 10.85 510,850
2014-10-01 Peltz Stuart Walter (Chief Executive Officer) Sale 41,501 43.01 1,785,082
2014-09-26 Rothera Mark (Chief Commercial Officer) Sale 3,000 46.90 140,700
2014-09-25 Rothera Mark (Chief Commercial Officer) Sale 10,100 44.53 449,803
2014-09-25 Rothera Mark (Chief Commercial Officer) Option Ex 7,100 10.85 77,035
2014-09-24 Rothera Mark (Chief Commercial Officer) Sale 2,900 43.37 125,772
2014-09-24 Rothera Mark (Chief Commercial Officer) Option Ex 900 10.85 9,765
2014-09-18 Jacobson Allan Steven (Director) Sale 2,000 40.16 80,320
2014-09-15 Rothera Mark (Chief Commercial Officer) Sale 8,000 36.27 290,160
2014-05-22 Kovacs Shane William Charles (Chief Financial Officer) Sale 1,650 14.74 24,321
2014-03-24 Peltz Stuart Walter (Chief Executive Officer) Sale 25,487 29.32 747,406
2014-03-21 Hirawat Claudia De Oliveira Ribeiro (President) Sale 15,320 30.02 459,952
2014-03-21 Southwell David P Sale 2,317 30.95 71,699
2014-03-20 Boulding Mark Elliott (Exec. VP and CLO) Sale 10,049 30.96 311,117
2014-03-19 Almstead Neil Gregory (Senior VP, Research and CMC) Sale 10,859 32.05 348,085
2014-03-18 Jacobson Allan Steven Sale 7,616 31.18 237,504
2014-03-14 Kranda Michael L Sale 1,186 31.02 36,789
2014-03-13 Spiegel Robert J. (Chief Medical Officer) Sale 1,186 31.75 37,655
2014-03-07 Peltz Stuart Walter (Chief Executive Officer) Sale 27,414 30.84 845,392
2014-02-19 Schmertzler Michael Buy 23,000 24.50 563,500
2013-12-17 Hbm Healthcare Investments (cayman) Ltd. Sale 66,667 19.08 1,272,139
2013-06-25 Vcvc Iii Llc Buy 333,333 15.00 4,999,995
2013-06-25 Bolte Axel (Director) Buy 20,000 15.00 300,000
2013-06-25 Koppel Adam (Director) Buy 1,250,000 15.00 18,750,000
2013-06-25 Rothera Mark (Chief Commercial Officer) Buy 25,000 15.00 375,000
2013-06-25 Schmertzler Michael (Director) Buy 533,333 15.00 7,999,995
2013-06-25 Hbm Healthcare Investments (cayman) Ltd. Buy 666,676 15.00 10,000,140
2013-06-25 Aldrich Richard (Director) Buy 766,667 15.00 11,500,005

Insider trading activities including stock purchases, stock sales, and option exercises of PTCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ptc Therapeutics, Inc. (symbol PTCT, CIK number 1070081) see the Securities and Exchange Commission (SEC) website.